title: Editorial comment on 'A novel approach indirectly comparing benefit: risk across oral antithrombotic therapies in patients with atrial fibrillation'. Are the evidences of current dose-adjusted anticoagulation with warfarin stroke prevention for patients with atrial fibrillation sufficient enough to compare with newly developed non-vitamin K oral anticoagulants?
authors.affiliation: Department of Medicine (Cardiology), Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1143, Japan.
authors.forename: Shinichi
authors.initials: S
authors.lastname: Goto
authors.affiliation: Department of Medicine (Cardiology), Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1143, Japan sgoto3@mac.com shinichi@is.icc.u-tokai.ac.jp.
authors.forename: Shinya
authors.initials: S
authors.lastname: Goto